BUPIVACAINE per RACHIANESTHESIE AGUETTANT 5 mg/ml, solution for injection (route intrarachidienne) 5 ampoules of 4 ml
Active ingredients: Bupivacaine hydrochloride, Bupivacaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection5 ampoules of 4 mlintrathécale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BUPIVACAINE POUR RACHIANESTHESIE AGUETTANT 5 mg/ml, solution injectable (voie intrarachidienne)
- Pharmaceutical form
- solution injectable
- Route of administration
- intrathécale
- Presentation description
- 5 ampoule(s) en verre de 4 ml
- Marketing authorisation holder
- AGUETTANT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Jan 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List II: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62837780CIP75606894CIP133400956068944Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUPIVACAÏNE (CHLORHYDRATE DE) MONOHYDRATÉsolution | 5,28 mg · 1 ml de solution injectable | SA |
| CHLORHYDRATE DE BUPIVACAÏNE ANHYDREsolution | 5,00 mg · 1 ml de solution injectable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.